RT Book, Section
A1 Fitzpatrick, Meghan E.
A1 Prendergast, Niall T.
A1 Rivera-Lebron, Belinda
A2 Papadakis, Maxine A.
A2 McPhee, Stephen J.
A2 Rabow, Michael W.
A2 McQuaid, Kenneth R.
SR Print(0)
ID 1193146405
T1 Alveolar Hemorrhage Syndromes
T2 Current Medical Diagnosis & Treatment 2023
YR 2023
FD 2023
PB McGraw-Hill Education
PP New York, NY
SN 9781264687343
LK accessmedicine.mhmedical.com/content.aspx?aid=1193146405
RD 2024/04/19
AB Diffuse  alveolar  hemorrhage  may  occur  in  a  variety  of  immune  and  nonimmune  disorders.  Alveolar  infiltrates  on  chest  radiograph,  dyspnea,  anemia,  hemoptysis  and,  occasionally,  fever  are  characteristic.  Rapid  clearing  of  diffuse  lung  infiltrates  within  2  days  is  a  clue  to  the  diagnosis  of  diffuse  alveolar  hemorrhage  (eFigure  9–23).  Pulmonary  hemorrhage  can  be  associated  with  an  increased  DLCO,  although  this  test  is  infrequently  obtained.  Sequential  BAL  on  bronchoscopy  is  the  preferred  method  for  diagnosis  with  lavage  aliquots  becoming  progressively  more  hemorrhagic.